leading semaglutide class action Ozempic Stomach Paralysis Lawsuits Ozempic Lawsuit: July 2026 Blindness

Preclinical studies have demonstrated that GLP-1R agonists can reduce the accumulation of amyloid plaques, a hallmark of Alzheimer's disease, and improve synaptic function

This includes 6% of adults who say they are currently taking one of these drugs, which include Ozempic, Wegovy and MounjaroThe shares of adults who report ever taking these drugs is highest among people with diabetes (43%), followed by those with heart disease (26%) and those who have obesity or overweight (22%), the poll finds

SGLT2, Sodium-glucose co-transporter-2

Clinical trials have shown significant weight loss in patients taking Semaglutide